Justiz-Vaillant, A.A.; Gopaul, D.; Akpaka, P.E.; Soodeen, S.; Arozarena Fundora, R. Severe Combined Immunodeficiency—Classification, Microbiology Association and Treatment. Microorganisms2023, 11, 1589.
Justiz-Vaillant, A.A.; Gopaul, D.; Akpaka, P.E.; Soodeen, S.; Arozarena Fundora, R. Severe Combined Immunodeficiency—Classification, Microbiology Association and Treatment. Microorganisms 2023, 11, 1589.
Justiz-Vaillant, A.A.; Gopaul, D.; Akpaka, P.E.; Soodeen, S.; Arozarena Fundora, R. Severe Combined Immunodeficiency—Classification, Microbiology Association and Treatment. Microorganisms2023, 11, 1589.
Justiz-Vaillant, A.A.; Gopaul, D.; Akpaka, P.E.; Soodeen, S.; Arozarena Fundora, R. Severe Combined Immunodeficiency—Classification, Microbiology Association and Treatment. Microorganisms 2023, 11, 1589.
Abstract
Severe combined immunodeficiency (SCID) is a primary inherited immunodeficiency that could be fatal, usually due to opportunistic infections caused by bacteria, viruses, fungi, and protozoa if left untreated. Opportunistic infections are the most common presentation of SCID these include viral, fungal, or intracellular bacteria, and infection should prompt immunological investigation. This review aimed to provide a comprehensive approach to the microrganisms associated with severe combined immunodeficiency (SCID) and its management. The authors described SCID as a syndrome and summarized the different microorganisms that affect children and how they are managed.
Keywords
Microorganisms; Severe combined immunodeficiency; Infectious diseases; Management; Antibi-otics; Antifungals; HST
Subject
Medicine and Pharmacology, Medicine and Pharmacology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
